We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RLX:NYSERLX Technology Inc. Analysis

Data as of 2026-03-16 - not real-time

$2.25

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

RLX Technology Inc. displays robust fundamentals, highlighted by rapid revenue expansion and solid profitability margins. The company generates ample operating cash flow and maintains a strong cash position relative to modest debt levels. Its dividend yield is notably high while the payout ratio remains comfortably low, suggesting sustainable shareholder returns. A discounted cash flow analysis points to a fair value far above the current market price, signalling a pronounced valuation gap. Coupled with a low beta, these attributes position the stock as fundamentally attractive.
On the technical front, the share price sits below its short‑term moving averages and the MACD indicates bearish momentum. RSI sits in a neutral zone, yet recent price action has been volatile, reflecting heightened short‑term uncertainty. The tobacco sector, while defensive, carries elevated regulatory scrutiny, especially given the company's China focus. Recent news of a substantial fourth‑quarter revenue increase provides a positive catalyst, but the price remains near a key support level. Investors should weigh the strong fundamentals against the near‑term technical weakness when forming a view.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • bearish MACD and price below short‑term averages
  • proximity to technical support level
  • high dividend yield offering downside protection

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • significant valuation discount to DCF fair value
  • strong revenue growth and cash generation
  • sustainable dividend supporting total return

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • durable cash reserves and low leverage
  • ongoing dividend sustainability
  • growth trajectory despite regulatory headwinds

Key Metrics & Analysis

Financial Health

Revenue Growth52.20%
Profit Margin23.35%
P/E Ratio25.0
ROE4.87%
ROA0.73%
Debt/Equity1.02
P/B Ratio1.2
Op. Cash Flow$1.3B
Free Cash Flow$367.3M

Technical Analysis

TrendBearish
RSI41.4
Support$2.19
Resistance$2.45
MA 20$2.32
MA 50$2.32
MA 200$2.34
MACDBearish
VolumeStable
Fear & Greed Index72.88

Valuation

Fair Value$17.30
Target Price$2.92
Upside/Downside30.00%
GradeUndervalued
TypeGrowth
Dividend Yield4.44%

Risk Assessment

Beta0.09
Volatility28.17%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.